RxDoctor Payments Data

Erich Kiehl, MD

Clinical Cardiac Electrophysiology · Newport News, VANPI 1184913501

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $124,609 of the $181,494 with a category attached, or 68.7%. Philips North America LLC accounts for 64.0% of it on its own, with 14 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$181,494in general payments, 2019–2025

Across 374 payments — averaging $485.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$116K
  • Medtronic$32K
  • Biosense Webster, Inc.$20K
  • Abbott$5K
  • Boston Scientific$3K
  • Biotronik Inc.$3K
  • plus $2K from 9 others
$680,866in research payments, 2019–2025

Across 102 payments — averaging $6675.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$355K
  • Boston Scientific$161K
  • Medtronic$142K
  • Biosense Webster, Inc.$21K
  • Eli Lilly$631
  • Eli Lilly Export S.A. Puerto Rico Branch$79

What the payments were for

  • Consulting fees$124,60969%
  • Speaking & faculty fees$4,7503%
  • Travel & lodging$39,18622%
  • Food & beverage$12,9507%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$181,494 in reported general payments places this provider in the 95th percentile of 90 clinical cardiac electrophysiology providers in Virginia.

See all clinical cardiac electrophysiology providers in Virginia

Medicare billing

Part B allowed, 2024
$386,575
Medicare patients
1,299
Services billed
4,390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban364$389,159
XareltoRivaroxaban86$120,102
MultaqDronedarone Hcl23$28,807
EntrestoSacubitril/Valsartan31$27,199
Dofetilide69$14,824
Flecainide Acetate125$5,100
Metoprolol Succinate100$1,464
Diltiazem 24hr Er (Cd)Diltiazem Hcl44$1,074
Amiodarone Hcl47$498
Metoprolol Tartrate40$387
Carvedilol33$298
Warfarin Sodium17$258
Furosemide29$134
Losartan Potassium14$109
Potassium Chloride12$75

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →